Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules

This article has been updated

Abstract

Phage-display of antibody libraries is a powerful tool to select antibodies for specific epitopes. We describe a strategy for selecting highly specific scFv-clones that discriminate between various conformational states of cell surface receptors. This approach adapts the M13 pIII phage-display technology toward a cell suspension-based strategy, which allows panning against complex, multimeric, fully functional cell membrane epitopes without alteration of structure due to purification or immobilization. As the functional properties are preserved, phage can be specifically depleted or selected for neo-epitopes exposed after physiological alterations of the targeted molecules. This subtractive strategy allows highly specific selection for single-chain antibodies directed against functionally regulated epitopes on the cell surface molecules that can be tailored for diagnostic and therapeutic applications. Using this protocol, activation-specific single-chain antibodies can be obtained within 4–6 weeks.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Single-chain antibody display on pIII of the M13 phage.
Figure 2: Flow chart of the subtractive panning (depletion/selection) strategy for the generation of conformation-specific single-chain antibodies.
Figure 3: Monitoring for success of the panning process.
Figure 4: Production and purification of selected single-chain antibodies in TG-1 Escherichia coli.

Similar content being viewed by others

Change history

  • 05 June 2008

    In the version of this article initially published, some reagents were referred to incorrectly or unclearly. In Step 11, “1 ml buffer” should have been “1 ml HEPES buffer”. In Step 48, “saccharose” should have been “sucrose”. In Box 2, Step 1, “LBG media” should have been “LB media”. Some units were listed incorrectly. In Box 1, Step 3, “1,000 g ml-1” should have been “100 μg ml-1”. In the table in Step 42, the four instances of “ml” should have been “μl”. In Box 2, Step 2, “Inoculate 5 ml LB media with 100 μl” should have been “Inoculate 500 ml LB media with 5 ml”. The relationship between Procedure steps and Figure 4 was unclear, leaving the figure open to misinterpretation. The following sentence has been added to the end of Step 53, before the Critical Step: “Figure 4 shows the successful production and purification of an scFv antibody as assessed by SDS–polyacrylamide gel electrophoresis and western blotting of an scFv cloned into the pHOG-21 vector expressed in TG-1 E. coli (Steps 58–70).” The two labels on Figure 4 that read “36,000 Da” have been changed to “scFv”. In the description of panel b in the legend, “anti-HIS-tag” has been changed to “anti-His-tag”. In Step 15, “XL-1 blue on 5 ml” should have been “XL-1 blue in 5 ml”. In the legend to Figure 3, the citation to ref. 18 should have been to ref. 5. At the end of the legend to Figure 4 and in “Anticipated Results,” the citation “18,20” should have been “4–6”. These errors have been corrected in the HTML and PDF versions of the article.

References

  1. Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Making antibody fragments using phage display libraries. Nature 352, 624–628 (1991).

    Article  CAS  Google Scholar 

  2. Giordano, R.J., Cardó-Vila, M., Lahdenranta, J., Pasqualini, R. & Arap, W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7, 1249–1253 (2001).

    Article  CAS  Google Scholar 

  3. Arap, W. et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8, 121–127 (2002).

    Article  CAS  Google Scholar 

  4. Schwarz, M. et al. Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries. FASEB J. 1704–1706 (2004).

  5. Eisenhardt, S.U. et al. Generation of activation-specific human anti-alphaM/beta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109, 3521–3528 (2007).

    Article  CAS  Google Scholar 

  6. Schwarz, M. et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ. Res. 99, 25–33 (2006).

    Article  CAS  Google Scholar 

  7. Fuchs, P., Breitling, F., Dübel, S., Seehaus, T. & Little, M. Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Biotechnology 9, 1369–1372 (1991).

    Article  CAS  Google Scholar 

  8. Zahnd, C., Amstutz, P. & Plückthun, A. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 4, 269–279 (2007).

    Article  CAS  Google Scholar 

  9. Roberts, R.W. & Szostak, J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 94, 12297–12302 (1997).

    Article  CAS  Google Scholar 

  10. Boder, E.T. & Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553–557 (1997).

    Article  CAS  Google Scholar 

  11. Smith, G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1317 (1985).

    Article  CAS  Google Scholar 

  12. Barbas, C.F. III, Kang, A.S., Lerner, R.A. & Benkovic, S.J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88, 7978–7982 (1991).

    Article  CAS  Google Scholar 

  13. Hust, M., Maiss, E., Jacobsen, H.J. & Reinard, T. The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease. J. Virol. Methods 106, 225–233 (2002).

    Article  CAS  Google Scholar 

  14. Hawlisch, H. et al. Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets. Anal. Biochem. 293, 142–145 (2001).

    Article  CAS  Google Scholar 

  15. Moghaddam, A. et al. Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J. Immunol. Methods 280, 139–155 (2003).

    Article  CAS  Google Scholar 

  16. Robert, R. et al. Identification of human scFvs targeting atherosclerotic lesions: selection by single round in vivo phage display. J. Biol. Chem. 281, 40135–40143 (2006).

    Article  CAS  Google Scholar 

  17. Little, M. et al. Generation of a large complex antibody library from multiple donors. J. Immunol. Methods 231, 3–9 (1999).

    Article  CAS  Google Scholar 

  18. Dörsam, H. et al. Antibodies to steroids from a small human naïve IgM library. FEBS Lett. 414, 7–13 (1997).

    Article  Google Scholar 

  19. Takagi, J. & Springer, T.A. Integrin activation and structural rearrangement. Immunol. Rev. 186, 141–163 (2002).

    Article  CAS  Google Scholar 

  20. Hynes, R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11–25 (1992).

    Article  CAS  Google Scholar 

  21. Eisenhardt, S.U. et al. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109, 3521–3528 (2007).

    Article  CAS  Google Scholar 

  22. Parsons, H.L. et al. Directing phage selections towards specific epitopes. Protein Eng. 9, 1043–1049 (1996).

    Article  CAS  Google Scholar 

  23. Osbourn, J.K., Derbyshire, E.J., Vaughan, T.J., Field, A.W. & Johnson, K.S. Pathfinder selection: in situ isolation of novel antibodies. Immunotechnology 3, 293–302 (1998).

    Article  CAS  Google Scholar 

  24. Osbourn, J.K. et al. Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library. Nat. Biotechnol. 16, 778–781 (1998).

    Article  CAS  Google Scholar 

  25. Levitan, B. Stochastic modeling and optimization of phage display. J. Mol. Biol. 277, 893–916 (1998).

    Article  CAS  Google Scholar 

  26. de Wildt, R.M., Mundy, C.R., Gorick, B.D. & Tomlinson, I.M. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18, 989–994 (2000).

    Article  CAS  Google Scholar 

  27. Le Gall, F., Kipriyanov, S.M., Moldenhauer, G. & Little, M. Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett. 453, 164–168 (1999).

    Article  CAS  Google Scholar 

  28. Kipriyanov, S.M., Moldenhauer, G. & Little, M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol. Methods 200, 69–77 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steffen U Eisenhardt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenhardt, S., Schwarz, M., Bassler, N. et al. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat Protoc 2, 3063–3073 (2007). https://doi.org/10.1038/nprot.2007.455

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2007.455

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing